Over-expressed Phospholamban in Cancer-associated Fibroblasts Is a Driver for CMS4 Subtype Colorectal Cancer FormationSummary
Background & Aims: Heterogeneity is the malignancy feature of colorectal cancer (CRC), which augments the difficulty of CRC treatment. Consensus molecular subtypes (CMSs) classified CRC into 4 subtypes. CMS4 is the most aggressive subtype, characterized with epithelial mesenchymal transition...
Saved in:
| Main Authors: | Tao Li, Yuxiang Fei, Xu Sun, Jun Zhu, Xin Fang, Fanjun Meng, Danyi Wang, Xu Zhang, Chao Liu, Qianming Du |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-01-01
|
| Series: | Cellular and Molecular Gastroenterology and Hepatology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352345X25000657 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive analysis of the critical role of the epithelial mesenchymal transition subtype - TAGLN-positive fibroblasts in colorectal cancer progression and immunosuppression
by: Junli Zhang, et al.
Published: (2025-05-01) -
Genetic landscape of phospholamban cardiomyopathies
by: Elizabeth Vafiadaki, et al.
Published: (2025-06-01) -
Cancer cell SPOCD1 promotes colorectal cancer liver metastasis by activating the CXCL12/CXCR4 signaling pathway in cancer-associated fibroblasts
by: Geng Peng, et al.
Published: (2025-08-01) -
Research progress on cancer-associated fibroblasts in malignant tumors
by: DU Yuxin, et al.
Published: (2025-05-01) -
Rosmarinic acid potentiates gefitinib in lung adenocarcinoma by modulating interactions between cancer cells and cancer-associated fibroblasts
by: Duo Li, et al.
Published: (2025-07-01)